Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Jan 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1915741000001116 | COVID-19 Vaccine Sputnik V Component II (recombinant serotype 5 adenoviral particles) 100,000,000,000 viral particles/0.5ml dose solution for injection vials (Gamaleya NRCEM) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1915751000001118 | COVID-19 Vaccine Sputnik V Component II (recombinant serotype 5 adenoviral particles) 100,000,000,000 viral particles/0.5ml dose solution for injection vials (Gamaleya NRCEM) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| COVID-19 Vaccine Sputnik V Component II (recombinant serotype 5 adenoviral particles) 100,000,000,000 viral particles/0.5ml dose solution for injection vials (Gamaleya NRCEM) | Is a | Generic COVID-19 Vaccine Sputnik V Component II (recombinant serotype 5 adenoviral particles) 100,000,000,000 viral particles/0.5ml dose solution for injection vials | true | Inferred relationship | Existential restriction modifier | ||
| COVID-19 Vaccine Sputnik V Component II (recombinant serotype 5 adenoviral particles) 100,000,000,000 viral particles/0.5ml dose solution for injection vials (Gamaleya NRCEM) | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction restricted availability | true | Inferred relationship | Existential restriction modifier | ||
| COVID-19 Vaccine Sputnik V Component II (recombinant serotype 5 adenoviral particles) 100,000,000,000 viral particles/0.5ml dose solution for injection vials (Gamaleya NRCEM) | Is a | Actual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| COVID-19 Vaccine Sputnik V Component II (recombinant serotype 5 adenoviral particles) 100,000,000,000 viral particles/0.5ml dose solution for injection vials (Gamaleya NRCEM) | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| COVID-19 Vaccine Sputnik V Component II (recombinant serotype 5 adenoviral particles) 100,000,000,000 viral particles/0.5ml dose solution for injection vials (Gamaleya NRCEM) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| COVID-19 Vaccine Sputnik V Component II (recombinant serotype 5 adenoviral particles) 100,000,000,000 viral particles/0.5ml dose solution for injection vials (Gamaleya NRCEM) | Has dispensed dose form | Conventional release solution for injection | true | Inferred relationship | Existential restriction modifier | ||
| COVID-19 Vaccine Sputnik V Component II (recombinant serotype 5 adenoviral particles) 100,000,000,000 viral particles/0.5ml dose solution for injection vials (Gamaleya NRCEM) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| COVID-19 Vaccine Sputnik V Component II (recombinant serotype 5 adenoviral particles) 100,000,000,000 viral particles/0.5ml dose solution for injection vials (Gamaleya NRCEM) | VMP prescribing status (attribute) | Never valid to prescribe as a VMP | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| COVID-19 Vaccine Sputnik V Component II (recombinant serotype 5 adenoviral particles) 100,000,000,000 viral particles/0.5ml dose solution for injection vials (Gamaleya NRCEM) 5 vial | Has AMP | True | COVID-19 Vaccine Sputnik V Component II (recombinant serotype 5 adenoviral particles) 100,000,000,000 viral particles/0.5ml dose solution for injection vials (Gamaleya NRCEM) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR